Pharmaceuticals, Biotechnology and Life Sciences
SAN DIEGO, Feb. 17, 2023 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today posted an update to its…
Oxurion Receives Transparency Notifications from Negma Group Leuven, BELGIUM, Boston, MA, US – February 17, 2022 – 7.00 PM CET…
NEW YORK, Feb. 16, 2023 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory…
MELBOURNE, Australia and SAN FRANCISCO, Feb. 16, 2023 (GLOBE NEWSWIRE) — Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the…
SAN DIEGO, Feb. 16, 2023 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report fourth quarter…
New Senior Leadership Role Will Streamline Alignment of All Company Revenue-Generating FunctionsMALVERN, Pa., Feb. 16, 2023 (GLOBE NEWSWIRE) — Neuronetics,…
HAYWARD, Calif., Feb. 16, 2023 (GLOBE NEWSWIRE) — Predicine, a global molecular insights company, is committed to advancing genitourinary (GU)…
SAN FRANCISCO, Feb. 16, 2023 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will provide a…
CAMBRIDGE, Mass., Feb. 16, 2023 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the…
ERYTECH and PHERECYDES Announce Proposed Combination Intending to Create Global Leader in Extended Phage Therapies Conference call and webcast in…